Skip to main content
UniHealth

Doctor search

Berkeley N Limketkai, MD

Gastroenterology · Los Angeles

NPI 1962609636

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
8

Offices

8 locations · The Regents of the University of California · 1,426 clinicians in this group

Looking this up.

Hospitals listed: Ronald Reagan UCLA Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Limketkai’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A132318 · Current

Licensed to practise in California · since 2014 · expires 2028-03-31 · University of Cincinnati College of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Ronald Reagan UCLA Medical CenterLos Angeles, CAAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Jonsson Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 79% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 6.27 (4.69 to 7.85) · 3,570 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 5.17 (1.78 to 8.56) · 1,778 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.21 (0 to 0.62) · 8,165 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.59, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.611, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.503, Oct 2024 – Sep 2025
See every measure and the patient survey for Ronald Reagan UCLA Medical Center

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Ronald Reagan UCLA Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths6.27 (4.69 to 7.85) · 3,570 casesWorseJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths5.17 (1.78 to 8.56) · 1,778 casesBetterJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.21 (0 to 0.62) · 8,165 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.59BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.611BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.503BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.67 (0 to 1.44) · 2,883 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.9 (0.7 to 1.09)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths171.14 (139.88 to 202.41) · 282 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.1 · 122 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.2 · 49 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.5 · 107 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths7.9 · 350 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths11.1 · 436 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths12.8 · 242 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.4 · 3,004 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 9,102 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.09 to 0.44) · 10,460 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.67 (0.57 to 2.77) · 1,972 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.27 to 3.44) · 3,000 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.93 (3.76 to 8.09) · 2,101 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.65 (1.31 to 3.98) · 1,032 casesNo differentJul 2022 – Jun 2024
MRSA BacteremiaInfections0.56No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.626No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.8 · 138 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.9 · 357 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-7.1 · 122 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-12.9 · 385 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits13.6 · 427 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.1 · 404 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.9 (3.7 to 6.5) · 609 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.3 (10.1 to 15) · 609 casesNo differentJan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits10.8 · 119 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.8 · 49 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits10.8 (8.5 to 13.7) · 2,701 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,463 casesNo differentJan 2024 – Dec 2024

What patients said (814 patients answered, 18% of those asked)

Patient survey stars by topic at Ronald Reagan UCLA Medical Center
Cleanliness3
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital4
Share of patients giving the best answer at Ronald Reagan UCLA Medical Center
Room was "always" clean72%
Nurses "always" communicated well77%
Doctors "always" communicated well78%
Staff "always" explained60%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand73%
Doctors "always" listened carefully76%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications74%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night43%
"YES", patients would definitely recommend the hospital79%
Staff "always" explained possible side effects45%
Yes, staff "did" give patients information about possible symptoms87%

Original Medicare doctor bills

$6,804

Medicare paid this office $6,804 for 31 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)14$1,933$102

Procedures Medicare counted

Procedure volume Medicare published
Colonoscopy16More than 45% of doctors who do this
Upper gastrointestinal (GI) endoscopy for acid reflux1-10None

Who their Medicare patients are

31 Original Medicare patients in 2024. Average age 67 · Women 58% · Also on Medicaid 36% · Health risk score 1.79. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.

Conditions among them: High blood pressure 68% · Diabetes 35% · Depression 35%.

The office billed $75,365, Medicare allowed $9,366 and paid $6,804; for 61 services of 12 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243161671.79$75,365$6,804
20235297651.62$141,255$12,432
202273121671.49$170,464$14,842
2021118226693.20$250,173$25,782
202084164702.88$132,072$18,462
201983152672.30$134,557$16,006
2018143321662.48$237,204$31,331
2017152383672.47$249,750$35,036
2016146292662.25$215,500$30,695
2015163332672.14$273,385$37,846
20141419651.58$19,483$2,322

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Original Medicare services billed in 2023
Return visit (30+ min)14$2,261$113
Biopsy of large bowel using a flexible endoscope17$2,174$128

2022: 4 services

Original Medicare services billed in 2022
Biopsy of large bowel using a flexible endoscope21$2,845$135
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk11$2,198$200
Long return visit (40+ min)12$1,911$136
Return visit (30+ min)13$1,710$95

2021: 6 services

Original Medicare services billed in 2021
Initial hospital care with moderate level of medical decision making at least 75 minutes18$3,113$173
Long return visit (40+ min)15$2,534$141
Removal of polyps or growths of large bowel using an endoscope with mechanical snare11$2,446$222
Return visit (30+ min)13$1,967$94
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes20$1,552$62
Biopsy of large bowel using a flexible endoscope15$1,504$100

2020: 3 services

Original Medicare services billed in 2020
Initial hospital care with moderate level of medical decision making at least 75 minutes26$4,579$176
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes20$1,780$61
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes11$1,557$92

2019: 4 services

Original Medicare services billed in 2019
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes12$2,116$92
New patient visit (60+ min)12$1,872$156
Long return visit (40+ min)12$1,427$110
Return visit (30+ min)12$953$73

2018: 9 services

Original Medicare services billed in 2018
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes24$2,933$122
Long return visit (40+ min)17$2,594$96
Diagnostic exam of large bowel using a flexible endoscope14$2,161$154
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes13$2,153$94
Long return visit (40+ min)17$2,090$95
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes12$850$65
Return visit (30+ min)11$777$60
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito22$101$5
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito11$48$4

2017: 12 services

Original Medicare services billed in 2017
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes12$6,544$93
Long return visit (40+ min)29$4,610$94
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes19$2,441$122
New patient visit (60+ min)16$2,405$150
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope18$2,203$116
Biopsy of large bowel using a flexible endoscope14$2,064$147
Return visit (30+ min)21$1,834$71
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope13$1,324$102
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes11$987$90
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes12$972$65
Short return visit (20+ min)12$593$42
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito35$182$5

2016: 7 services

Original Medicare services billed in 2016
Long return visit (40+ min)35$5,265$96
Return visit (30+ min)26$2,196$63
New patient visit (60+ min)18$2,174$121
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes17$2,143$119
Biopsy of large bowel using a flexible endoscope13$1,901$146
New patient visit (45+ min)13$1,470$113
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes11$882$63

2015: 10 services

Original Medicare services billed in 2015
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes31$4,028$122
Long return visit (40+ min)21$3,670$99
Biopsy of large bowel using a flexible endoscope19$3,614$190
New patient visit (60+ min)18$2,582$143
New patient visit (45+ min)21$2,419$115
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope21$2,313$110
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$2,235$93
Return visit (30+ min)25$2,175$68
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope14$1,441$103
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes17$1,426$65

Drugs they prescribed that Part D paid

$1,689,482

Pharmacies billed $1,689,482 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 141) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.

58 generic and 83 brand-name prescriptions · $1,689,482 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Stelara45$1,215,744$27,017
Humira(Cf)16$232,352$14,522
Mesalamine23$7,600$330

Year by year

Part D prescribing by year
2024141290% (0)59%$1,689,482
2023133330% (0)62%$1,441,336
2022133670% (0)59%$1,033,644
2021108540% (0)44%$303,214
202039110% (0)49%$176,513
2019108260% (0)53%$290,340
2018251690% (0)49%$261,669
2017195520% (0)37%$155,998
2016214500% (0)43%$152,809
2015136520% (0)47%$72,133
201413None0% (0)None$439
201315None0% (0)0%$464

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 3 drugs

Part D drugs prescribed in 2023
Stelara38$1,000,794$26,337
Humira(Cf)18$264,399$14,689
Mesalamine16$8,454$528

2022: 4 drugs

Part D drugs prescribed in 2022
Stelara30$774,163$25,805
Mesalamine12$6,572$548
Gavilyte-G22$301$14
Peg-3350 and Electrolytes13$154$12

2021: 1 drug

Part D drugs prescribed in 2021
Gavilyte-C12$148$12

2019: 2 drugs

Part D drugs prescribed in 2019
Humira(Cf)11$117,348$10,668
Lactated Ringers13$274$21

2018: 6 drugs

Part D drugs prescribed in 2018
Humira18$118,497$6,583
Budesonide Ec18$13,772$765
Hydrocortisone11$1,146$104
Lactated Ringers46$813$18
Peg 3350-Electrolyte18$291$16
Prednisone14$118$8

2017: 4 drugs

Part D drugs prescribed in 2017
Humira18$101,383$5,632
Polyethylene Glycol 335018$1,269$70
Peg 3350-Electrolyte14$211$15
Omeprazole13$78$6

2016: 6 drugs

Part D drugs prescribed in 2016
Humira17$105,224$6,190
Pentasa13$10,940$842
Dexilant13$3,233$249
Esomeprazole Magnesium13$1,280$98
Loperamide15$287$19
Omeprazole11$217$20

2015: 3 drugs

Part D drugs prescribed in 2015
Pentasa14$6,061$433
Peg 3350-Electrolyte18$339$19
Pantoprazole17$235$14

Money from drug and device companies

$74,572 in 2025

Industry payments by year
2025156$64,225$74,572
2024119$18,419$20,384
202324None$456
202222None$190
202011None$22
201916None$152

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Janssen BiotechTremfya$74,572
56 payments
  • Paid to speak or teach for Tremfya · 2025-12-06 · $3,150
  • Meals for Tremfya · 2025-12-02 · $149
  • Travel for Tremfya · 2025-11-24 · $291
  • Paid to speak or teach for Tremfya · 2025-11-22 · $4,900
  • Meals for Tremfya · 2025-11-19 · $125
  • Travel for Tremfya · 2025-11-19 · $265
  • Travel for Tremfya · 2025-11-19 · $166
  • Paid to speak or teach for Tremfya · 2025-11-08 · $4,900
  • Paid to speak or teach for Tremfya · 2025-11-08 · $4,900
  • Meals for Tremfya · 2025-11-06 · $146
  • Travel for Tremfya · 2025-11-05 · $293
  • Travel for Tremfya · 2025-11-05 · $1,842
  • Travel for Tremfya · 2025-11-05 · $152
  • Meals for Tremfya · 2025-11-05 · $125
  • Travel for Tremfya · 2025-10-27 · $310
  • Paid to speak or teach for Stelara · 2025-10-25 · $1,400
  • Paid to speak or teach for Tremfya · 2025-10-25 · $3,150
  • Meals for Tremfya · 2025-10-21 · $114
  • Paid to speak or teach for Tremfya · 2025-10-18 · $4,900
  • Travel for Tremfya · 2025-10-15 · $417
  • Meals for Tremfya · 2025-10-15 · $150
  • Travel for Tremfya · 2025-10-15 · $189
  • Travel for Tremfya · 2025-09-02 · $352
  • Paid to speak or teach for Tremfya · 2025-08-23 · $4,900
  • Travel for Tremfya · 2025-08-20 · $255
  • Travel for Tremfya · 2025-08-20 · $240
  • Meals for Tremfya · 2025-08-20 · $132
  • Paid to speak or teach for Tremfya · 2025-08-16 · $1,400
  • Paid to speak or teach for Stelara · 2025-07-05 · $875
  • Paid to speak or teach for Tremfya · 2025-06-06 · $66
  • Paid to speak or teach for Tremfya · 2025-05-31 · $1,400
  • Travel for Tremfya · 2025-05-28 · $147
  • Travel for Tremfya · 2025-05-28 · $171
  • Paid to speak or teach for Tremfya · 2025-05-24 · $3,150
  • Paid to speak or teach for Tremfya · 2025-05-24 · $4,900
  • Travel for Tremfya · 2025-05-22 · $268
  • Meals for Tremfya · 2025-05-22 · $143
  • Meals for Tremfya · 2025-05-20 · $150
  • Travel for Tremfya · 2025-05-20 · $740
  • Paid to speak or teach for Tremfya · 2025-05-17 · $7,700
  • Paid to speak or teach for Tremfya · 2025-05-03 · $3,150
  • Meals for Tremfya · 2025-04-29 · $130
  • Meals for Tremfya · 2025-04-11 · $57
  • Meals for Tremfya · 2025-04-11 · $150
  • Meals for Tremfya · 2025-04-11 · $32
  • Meals for Tremfya · 2025-04-11 · $38
  • Travel for Tremfya · 2025-04-10 · $194
  • Travel for Tremfya · 2025-04-10 · $669
  • Meals for Tremfya · 2025-04-10 · $100
  • Paid to speak or teach for Tremfya · 2025-03-22 · $3,128
  • Travel for Tremfya · 2025-03-12 · $634
  • Paid to speak or teach for Tremfya · 2025-02-28 · $3,128
  • Meals for Tremfya · 2025-02-27 · $146
  • Paid to speak or teach for Tremfya · 2025-02-01 · $3,128
  • Travel for Tremfya · 2025-01-29 · $740
  • Meals for Tremfya · 2025-01-29 · $124
See all 56 published payments
Every published payment
Janssen BiotechPaid to speak or teach · 2025-12-06Tremfya$3,150
Janssen BiotechMeals · 2025-12-02Tremfya$149
Janssen BiotechTravel · 2025-11-24Tremfya$291
Janssen BiotechPaid to speak or teach · 2025-11-22Tremfya$4,900
Janssen BiotechMeals · 2025-11-19Tremfya$125
Janssen BiotechTravel · 2025-11-19Tremfya$265
Janssen BiotechTravel · 2025-11-19Tremfya$166
Janssen BiotechPaid to speak or teach · 2025-11-08Tremfya$4,900
Janssen BiotechPaid to speak or teach · 2025-11-08Tremfya$4,900
Janssen BiotechMeals · 2025-11-06Tremfya$146
Janssen BiotechTravel · 2025-11-05Tremfya$293
Janssen BiotechTravel · 2025-11-05Tremfya$1,842
Janssen BiotechTravel · 2025-11-05Tremfya$152
Janssen BiotechMeals · 2025-11-05Tremfya$125
Janssen BiotechTravel · 2025-10-27Tremfya$310
Janssen BiotechPaid to speak or teach · 2025-10-25Stelara$1,400
Janssen BiotechPaid to speak or teach · 2025-10-25Tremfya$3,150
Janssen BiotechMeals · 2025-10-21Tremfya$114
Janssen BiotechPaid to speak or teach · 2025-10-18Tremfya$4,900
Janssen BiotechTravel · 2025-10-15Tremfya$417
Janssen BiotechMeals · 2025-10-15Tremfya$150
Janssen BiotechTravel · 2025-10-15Tremfya$189
Janssen BiotechTravel · 2025-09-02Tremfya$352
Janssen BiotechPaid to speak or teach · 2025-08-23Tremfya$4,900
Janssen BiotechTravel · 2025-08-20Tremfya$255
Janssen BiotechTravel · 2025-08-20Tremfya$240
Janssen BiotechMeals · 2025-08-20Tremfya$132
Janssen BiotechPaid to speak or teach · 2025-08-16Tremfya$1,400
Janssen BiotechPaid to speak or teach · 2025-07-05Stelara$875
Janssen BiotechPaid to speak or teach · 2025-06-06Tremfya$66
Janssen BiotechPaid to speak or teach · 2025-05-31Tremfya$1,400
Janssen BiotechTravel · 2025-05-28Tremfya$147
Janssen BiotechTravel · 2025-05-28Tremfya$171
Janssen BiotechPaid to speak or teach · 2025-05-24Tremfya$3,150
Janssen BiotechPaid to speak or teach · 2025-05-24Tremfya$4,900
Janssen BiotechTravel · 2025-05-22Tremfya$268
Janssen BiotechMeals · 2025-05-22Tremfya$143
Janssen BiotechMeals · 2025-05-20Tremfya$150
Janssen BiotechTravel · 2025-05-20Tremfya$740
Janssen BiotechPaid to speak or teach · 2025-05-17Tremfya$7,700
Janssen BiotechPaid to speak or teach · 2025-05-03Tremfya$3,150
Janssen BiotechMeals · 2025-04-29Tremfya$130
Janssen BiotechMeals · 2025-04-11Tremfya$57
Janssen BiotechMeals · 2025-04-11Tremfya$150
Janssen BiotechMeals · 2025-04-11Tremfya$32
Janssen BiotechMeals · 2025-04-11Tremfya$38
Janssen BiotechTravel · 2025-04-10Tremfya$194
Janssen BiotechTravel · 2025-04-10Tremfya$669
Janssen BiotechMeals · 2025-04-10Tremfya$100
Janssen BiotechPaid to speak or teach · 2025-03-22Tremfya$3,128
Janssen BiotechTravel · 2025-03-12Tremfya$634
Janssen BiotechPaid to speak or teach · 2025-02-28Tremfya$3,128
Janssen BiotechMeals · 2025-02-27Tremfya$146
Janssen BiotechPaid to speak or teach · 2025-02-01Tremfya$3,128
Janssen BiotechTravel · 2025-01-29Tremfya$740
Janssen BiotechMeals · 2025-01-29Tremfya$124
See earlier years (2024, 2023, 2022, 2020, 2019)

2024: $20,384

Payments by company in 2024
Janssen BiotechTremfya$20,384
19 payments
  • Paid to speak or teach for Tremfya · 2024-11-30 · $3,128
  • Meals for Tremfya · 2024-11-21 · $118
  • Paid to speak or teach for Stelara · 2024-10-28 · $4,865
  • Travel for Stelara · 2024-10-21 · $28
  • Travel for Tremfya · 2024-10-21 · $3
  • Travel for Stelara · 2024-10-21 · $67
  • Travel for Tremfya · 2024-10-21 · $25
  • Paid to speak or teach for Tremfya · 2024-10-19 · $3,128
  • Meals for Tremfya · 2024-10-17 · $112
  • Paid to speak or teach for Tremfya · 2024-10-12 · $3,128
  • Meals for Tremfya · 2024-10-10 · $125
  • Travel for Tremfya · 2024-10-10 · $634
  • Meals for Stelara · 2024-09-28 · $39
  • Meals for Stelara · 2024-09-28 · $59
  • Meals for Stelara · 2024-09-28 · $38
  • Meals for Stelara · 2024-09-27 · $150
  • Travel for Stelara · 2024-09-27 · $248
  • Travel for Stelara · 2024-09-27 · $318
  • Consulting for Tremfya · 2024-07-27 · $4,170

2023: $456

Payments by company in 2023
Nestle Healthcare NutritionNone$310
3 payments
  • Meals · 2023-04-20 · $178
  • Meals · 2023-04-19 · $24
  • Meals · 2023-04-19 · $108
Janssen BiotechStelara$147
1 payment
  • Meals for Stelara · 2023-08-23 · $147

2022: $190

Payments by company in 2022
Boston ScientificResolution Clip$161
1 payment
  • Meals for Resolution Clip · 2022-03-04 · $161
AbbvieSkyrizi$29
1 payment
  • Meals for Skyrizi · 2022-10-07 · $29

2020: $22

Payments by company in 2020
AbbVieHumira$22
1 payment
  • Meals for Humira · 2020-09-04 · $22

2019: $152

Payments by company in 2019
Takeda Pharmaceuticals U.S.A.Entyvio$152
6 payments
  • Meals for Entyvio · 2019-10-28 · $22
  • Meals for Entyvio · 2019-10-28 · $29
  • Meals for Entyvio · 2019-10-28 · $29
  • Meals for Entyvio · 2019-10-28 · $22
  • Meals for Entyvio · 2019-10-28 · $29
  • Meals for Entyvio · 2019-10-28 · $22

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
86.1 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1962609636
Licence
CA A132318California A132318: Current · expires 2028-03-31
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
Mailing address
5767 W Century Blvd Ste 400, Los Angeles, CA, 90045
NPI first listed
2007-06-27
NPI last updated
2019-09-30

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Pasteur Drive, Stanford, CA, 94305